|
ESCO2 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.815400E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.268400E-01 |
| Normal-vs-Stage2 |
2.378800E-01 |
| Normal-vs-Stage3 |
9.620600E-01 |
| Normal-vs-Stage4 |
5.638800E-01 |
| Stage1-vs-Stage2 |
1.139770E-03 |
| Stage1-vs-Stage3 |
5.151600E-01 |
| Stage1-vs-Stage4 |
6.176800E-01 |
| Stage2-vs-Stage3 |
2.144300E-02 |
| Stage2-vs-Stage4 |
1.053880E-02 |
| Stage3-vs-Stage4 |
3.773200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.163800E-01 |
| Normal-vs-AfricanAmerican |
7.444600E-01 |
| Normal-vs-Asian |
8.648200E-01 |
| Caucasian-vs-AfricanAmerican |
3.065600E-01 |
| Caucasian-vs-Asian |
6.257200E-01 |
| AfricanAmerican-vs-Asian |
5.053200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.750400E-01 |
| Normal-vs-Female |
8.866200E-01 |
| Male-vs-Female |
9.606600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.230000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.136400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.894200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.261600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.397000E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.434810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.689000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.886750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.554500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.225980E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.543420E-01 |
| Classical-VS-Follicular |
3.22189996904143E-09 |
| Classical-VS-Other |
2.857600E-01 |
| Classical-VS-Normal |
5.521400E-01 |
| Tall-VS-Follicular |
4.795500E-04 |
| Tall-VS-Other |
1.390620E-01 |
| Tall-VS-Normal |
1.926840E-01 |
| Follicular-VS-Other |
4.920800E-01 |
| Follicular-VS-Normal |
1.111170E-01 |
| Other-VS-Normal |
4.935000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.415200E-01 |
| Normal-vs-N1 |
8.250400E-01 |
| N0-vs-N1 |
3.095400E-01 |
|
|
